Dr. Matthew Taub treats patients with cancer as an oncologist at Everglades Oncology and Hematology in Florida. Emphasizing evidence-based care, Dr. Matthew Taub also has extensive experience as a practicing hematologist focused on blood-related diseases.
As reported in the Oncology Times, one promising area of treatment involves the use of immunotherapy to address hematologic malignancies. One type of immunotherapy, allogeneic hematopoietic stem cell transplantation (HCT), has been employed for decades and has proved invaluable in treating leukemia in patients who undergo stem cell transplantation.
Immunological responses are a critical factor when undertaking HCT stem cell grafts, as the body often mounts immune responses against the transplants. Individualizing the immunotherapy approach with the help of big data enables the graft-versus-leukemia effect without triggering graft-versus-host disease.
Another advancement in immunotherapy involves CAR T-cell therapy, which has been FDA approved since 2017 and is effective in treating acute lymphoblastic leukemia. The new approach involves reprogramming healthy cells in ways that direct them to destroy cancer cells.